Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
211 participants
INTERVENTIONAL
2006-04-30
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations
NCT00231426
AVEIR Remote Care System Non-Significant Risk Study
NCT06542133
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
NCT06055751
Adaptive Cardiac Resynchronization Therapy in Patients With RBBB
NCT05936294
ACC - Atrial Contribution to CRT
NCT00180323
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AV Therapy Assessment group
appropriate system performance of the atrial and ventricular tachyarrhythmia therapies in the ASSURE device
AV Therapy Assessment-B301 investigational device
Atrial and ventricular tachyarrhythmia therapy delivered by the B301 investigational device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AV Therapy Assessment-B301 investigational device
Atrial and ventricular tachyarrhythmia therapy delivered by the B301 investigational device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is implanted with an investigational B301 device as part of the REASSURE AV study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alaska Heart Institute
Anchorage, Alaska, United States
Northern California Heart Care
Larkspur, California, United States
Orlando Regional Hospital
Orlando, Florida, United States
Heart and Vascular Institute
St. Petersburg, Florida, United States
Piedmont Hospital
Atlanta, Georgia, United States
St. Joseph Hospital
Savannah, Georgia, United States
Good Samaritan Hospital
Downers Grove, Illinois, United States
Heart Care Research Foundation
Merrionette Park, Illinois, United States
St. Mary Medical Center
Hobart, Indiana, United States
Mercy Hospital Medical Center
Des Moines, Iowa, United States
Central Baptist Hospital
Lexington, Kentucky, United States
Louisville Cardiology Medical Group
Louisville, Kentucky, United States
Medical Center Cardiologist Research
Louisville, Kentucky, United States
Owensboro Mercy Health System
Owensboro, Kentucky, United States
Ochsner Foundation Hospital
New Orleans, Louisiana, United States
Boston Medical Center
Boston, Massachusetts, United States
Lahey Clinic Medical Center
Burlington, Massachusetts, United States
Baystate Medical Center
Springfield, Massachusetts, United States
University of Massachusetts
Worcester, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
Saint Mary's Duluth Clinic
Duluth, Minnesota, United States
St. Anthony's Medical Center
St Louis, Missouri, United States
Sunrise Hospital & Medical Center
Las Vegas, Nevada, United States
Deborah Heart and Lung Center
Browns Mills, New Jersey, United States
Mount Sinai Medical Center
New York, New York, United States
Christ Hospital - Cincinnati
Cincinnati, Ohio, United States
The Cleveland Clinic Foundation
Cleveland, Ohio, United States
Ohio State University Medical Center
Columbus, Ohio, United States
Hillcrest Medical Center
Tulsa, Oklahoma, United States
Abington Memorial Hospital
Abington, Pennsylvania, United States
Reading Hospital and Medical Center
West Reading, Pennsylvania, United States
Baylor University Medical Center
Dallas, Texas, United States
Center For Cardiac Arrhythmias
Houston, Texas, United States
Inova Fairfax Hospital
Fairfax, Virginia, United States
Sentara Norfolk General Hospital
Norfolk, Virginia, United States
Chippenham Medical Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G040067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.